FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and upAn FDA advisory panel on Thursday unanimously endorsed the use of Moderna's trivalent flu vaccine candidate, which uses mRNA technology that's come under fire from the nation's top health official. In two 9-0 votes, the Vaccines and Related Biological Products Advisory Committee said the benefits of the mRNA vaccine outweigh its risks for preventing the flu in adults 50 to 64 years and in those 65 and up. "I do believe the data presented support that the benefits of the vaccine in both age groups...